Results 201 to 210 of about 15,589 (284)

Identifying the risk factors and developing a predictive model for postoperative pelvic floor dysfunction in cervical cancer patients. [PDF]

Transl Cancer Res, 2023
Liu YY, Zhu WH, Li W, Hao X, Zheng W, Shen Q.   +5 more
europepmc   +1 more source

Long‐term cost‐effectiveness of invasive urodynamic studies for overactive bladder in women

BJU International, Volume 136, Issue 1, Page 82-94, July 2025.
Objectives To estimate the cost‐effectiveness of using invasive urodynamic studies (UDS) in the management of women with refractory overactive bladder (OAB) symptoms using the results of the FUTURE trial. Patients and Methods The FUTURE study is the largest randomised controlled trial evaluating the clinical effectiveness of UDS with comprehensive ...
Helen Bell‐Gorrod, Praveen Thokala, Suzanne Breeman, David Cooper, Graeme MacLennan, Mohamed Abdel‐Fattah, Simon Dixon   +6 more
wiley   +1 more source

Pelvic floor muscle function and symptoms of dysfunctions in midwifes and nurses of reproductive age with and without pelvic floor dysfunction

, 2019
Gökhan Tosun, Nuri Peker, Özge Çeliker Tosun, Özgür Yeniel, Ahmet Mete Ergenoğlu, Ata Elvan, Meriç Yıldırım   +6 more
openalex   +1 more source

Screening for Incidence and Effect of Pelvic Floor Dysfunction in College-Aged Athletes. [PDF]

Int J Sports Phys Ther
Salvo CJ, Crewe A, Estes D, Kroboth J, Yost C.   +4 more
europepmc   +1 more source

High‐throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin‐deficient limb girdle muscular dystrophy

British Journal of Pharmacology, Volume 182, Issue 13, Page 2930-2949, July 2025.
Abstract Background and Purpose Limb‐girdle muscular dystrophy R2 (LGMD R2) is a rare genetic disorder characterised by progressive weakness and wasting of proximal muscles. LGMD R2 is caused by the loss of function of dysferlin, a transmembrane protein crucial for plasma membrane repair in skeletal muscles.
Celine Bruge, Nathalie Bourg, Emilie Pellier, Johana Tournois, Jerome Polentes, Manon Benabides, Noella Grossi, Anne Bigot, Anthony Brureau, Isabelle Richard, Xavier Nissan   +10 more
wiley   +1 more source

Impact of Strength and Nature of Patient Health Values on Compliance and Outcomes for Physiotherapy Treatment for Pelvic Floor Dysfunction

, 2019
Phil Reed, Catherine Whittall, Lisa A. Osborne, Simon Emery   +3 more
openalex   +2 more sources

Epidemiology of Pelvic Floor Dysfunction in the Tacna Region of Peru, 2023. [PDF]

Int Urogynecol J
Sologuren-García G, Linares CL, Flores JR, Escobar-Bermejo G, Sotelo-Gonzales S, Fagerstrom CK.   +5 more
europepmc   +1 more source

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma

Clinical Endocrinology, Volume 103, Issue 1, Page 21-35, July 2025.
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder, Cherie Chiang, Grace Kong, Michael Michael, Nirupa Sachithanandan, Emma Boehm   +5 more
wiley   +1 more source

Intravaginal electrical stimulation for the treatment of pelvic floor dysfunction: a systematic review and meta-analysis. [PDF]

Front Neurol
Chen R, Wang R, Yu Y, Zhao K, Li J.
europepmc   +1 more source

Care pathways and anorectal evaluation for obstetric anal sphincter injury‐related incontinence: A UK survey of obstetricians

Colorectal Disease, Volume 27, Issue 7, July 2025.
Abstract Aim To report on national clinical practice in relation to the post‐partum management of patients with obstetric anal sphincter injury (OASI)‐related incontinence in the UK. Method This was a cross‐sectional, observational study of maternity units in the National Health Service (NHS).
N. Elsaid, G. P. Thomas, S. Dutta, R. J. Fernando, E. V. Carrington, C. J. Vaizey   +5 more
wiley   +1 more source